AUG 18, 2026 · JOURNAL ARTICLE
Glucagon-Like Peptide-1–Based Therapies in Cardiovascular Disease: Evidence, Mechanisms, and Emerging Clinical Applications
European Journal of Preventive Cardiology
A narrative review synthesizing evidence on GLP-1 and GIP/GLP-1 therapies across cardiovascular disease, diabetes, obesity, and heart failure—providing expert synthesis rather than new primary data.
Study details
DesignNarrative review